Zimmer Biomet Q3 Earnings Top but Revenue Miss Causes Pre-Market DropZacks Investment Research • 11/05/25
Zimmer Biomet Stock Falls As Weakness In Latin America And Certain EU Markets Impact Organic Growth ForecastBenzinga • 11/05/25
Zimmer cuts 2025 organic sales growth forecast on weakness in international marketsReuters • 11/05/25
Zimmer Biomet Announces FDA Breakthrough Designation for World's First Iodine-Treated Total Hip Replacement SystemPRNewsWire • 10/28/25
Will Zimmer (ZBH) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research • 10/23/25
Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual MeetingPRNewsWire • 10/21/25
Zimmer Biomet Q3 Earnings To Highlight Innovation And Growth - Why I Think It's A BuySeeking Alpha • 10/12/25
The Launch of Foot and Ankle Trauma Solutions May Boost ZBH StockZacks Investment Research • 10/10/25
Zimmer Biomet Launches Two New Foot and Ankle Solutions for Complex Trauma CasesPRNewsWire • 10/08/25
I2Pure Celebrates Zimmer Biomet's Historic Approval of Iodine-Treated Implant System & Confirms AAHKS AttendanceBusiness Wire • 10/06/25
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2025 Financial ResultsPRNewsWire • 10/03/25
ZBH Receives PMDA Approval in Japan for iTaperloc Complete and iG7Zacks Investment Research • 10/02/25
Zimmer Biomet Announces Japan PMDA Approval of World's First Iodine-Treated Total Hip Replacement SystemPRNewsWire • 09/25/25
Zimmer Biomet Holdings, Inc. (ZBH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)Seeking Alpha • 09/08/25